Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Naloxegol

A peripherally acting mu-opioid receptor antagonist, approved in 2014 for opioid-induced constipation in adults with chronic non-cancer pain. This family brings together the active ingredient.

Did you know?It is a naloxol molecule linked to a polyethylene glycol (PEG) chain: this tail stops it from crossing the blood-brain barrier, so it acts on the gut but not on the brain.

NaloxegolGo to the active ingredient →
NaloxegolActive ingredientNaloxegolCat. No. P-N016-001CAS 854601-70-0

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.